Valuation : Omnicell, Inc.

Market Cap 1.57B 1.35B 1.27B 1.16B 2.16B 148B 2.17B 15.04B 5.81B 75.93B 5.89B 5.76B 242B P/E 2026 *
35x
P/E 2027 * 33.9x
Enterprise Value 1.57B 1.35B 1.27B 1.16B 2.16B 148B 2.17B 15.04B 5.81B 75.93B 5.89B 5.76B 242B EV / Sales 2026 *
1.27x
EV / Sales 2027 * 1.22x
Free-Float
76.4%
Yield 2026 *
-
Yield 2027 * -
1 day-1.29%
1 week-2.25%
Current month-2.25%
1 month-6.63%
3 months-20.07%
6 months-16.78%
Current year-24.13%
1 week 34
Extreme 34
35.38
1 month 32.53
Extreme 32.53
37.96
Current year 31.75
Extreme 31.75
55
1 year 29.06
Extreme 29.06
55
3 years 22.66
Extreme 22.66
56.06
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 01/10/2002
Director of Finance/CFO 56 15/09/2025
President 50 01/07/2026
Director TitleAgeSince
Chairman 68 01/09/1992
Director/Board Member 70 01/01/2013
Director/Board Member 70 01/01/2014
Date Insider Type Main position Quantity % Market Cap. Importance
17/8/26 Sell

Chairperson

-3,083 0.0068%
15/8/26 Tax

Chief Executive Officer

-12,350 0.0272%
15/8/26 Tax

Chief Administrative Officer

-4,025 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
-1.29%-2.25%+7.04%-38.11% 1.57B
-3.27%-3.71%+0.79%+23.91% 44.54B
+0.58%-3.87%-43.38%+132.73% 12.71B
-3.51%-5.08%-15.30%+75.34% 5.63B
-1.61%-2.94%+57.42% - 4.25B
+0.31%+7.33% - - 2.1B
+1.93%-0.76%-34.42% - 1.08B
+0.59%+1.38%+22.62%+147.60% 1.02B
-1.83%-8.29%+39.00%+47.04% 915M
+0.19%+0.19%-1.03%-62.24% 819M
Average -0.79%-1.33%+3.64%+46.61% 7.46B
Weighted average by Cap. -2.21%-1.52%-4.50%+48.50%

Financials

2026 *2027 *
Net sales 1.24B 1.06B 1B 913M 1.71B 117B 1.71B 11.86B 4.59B 59.91B 4.65B 4.54B 191B 1.29B 1.11B 1.04B 951M 1.78B 122B 1.78B 12.36B 4.78B 62.39B 4.84B 4.73B 199B
Net income 45.27M 38.94M 36.62M 33.43M 62.52M 4.28B 62.72M 434M 168M 2.19B 170M 166M 6.98B 47.37M 40.74M 38.31M 34.97M 65.41M 4.48B 65.62M 454M 176M 2.29B 178M 174M 7.31B
Net Debt - -
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,485
Date Price Change Volume
04/09/26 US$34.37 -1.29% 873,122
03/09/26 US$34.82 +0.32% 673,323
02/09/26 US$34.71 +0.58% 634,539
01/09/26 US$34.51 -1.85% 805,567
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
34.37USD
Average target price
57.86USD
Spread / Average Target
+68.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OMCL Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!